Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 6, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 6, 2024Not yet recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:February 2, 2024Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 26, 2024Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 7, 2024Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 31, 2016Unknown status
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 6, 2013Unknown status
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:November 19, 2021Unknown status
Condition(s):Unresectable Intrahepatic CholangiocarcinomaLast Updated:February 20, 2024Completed
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:September 13, 2023Recruiting
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 22, 2018Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.